Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 1911-1916

  Norris, M D ^a   Bordow, S B ^a   Haber, P S ^b   Marshall, G M ^a   Kavallaris, M ^a   Madafiglio, J ^a   Cohn, S L ^c   Salwen, H ^c   Schmidt, M L ^d   Hipfner, D R ^e   Cole, S P C ^e   Deeley, R G ^e   Haber, M ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Antisense RNA; Multidrug resistance; Multidrug resistance associated protein (MRP) gene; MYCN oncogene; Neuroblastoma; Polymerase chain reaction (PCR)

Indexed keywords

CANCER SURVIVAL; CONFERENCE PAPER; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC REGULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NEUROBLASTOMA; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TRANSCRIPTION REGULATION;

AGE FACTORS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; GENES, MYC; HUMANS; INFANT; NEUROBLASTOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RNA, ANTISENSE; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031417653     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00284-0     Document Type: Conference Paper

References (29)

1. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
2. Brodeur GM, Azar C, Brother M, et al. Neuroblastoma: effect of genetic factors on prognosis and treatment. Cancer 1992, 70, 1685-1694.
3. Schwab M., Varmus H. E., Bishop J. M. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature. 316:1985;160-162.
4. Thiele C. J., Reynolds C. P., Israel M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 313:1985;404-406.
5. Schwab M. Molecular cytogenetics of human neuroblastoma. Biochim Biophys Acta. 1114:1992;43-50.
6. Roninson IB, ed. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum, New York, 1991.
7. Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258, 1650-1654.
8. Bordow S. B., Haber M., Madafiglio J., et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 54:1994;5036-5040.
9. Norris M. D., Bordow S. B., Marshall G. M., et al. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med. 334:1996;231-238.
10. Telford D. J., Kavallaris M., White L., et al. Association of N-myc amplification with neuroblastoma: The Australian and New Zealand experience. J Paediatr Child Health. 28:1992;58-63.
11. Cohn SL, Salwen H, Quasney MW, et al. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene 1990, 5, 1821-1827.
12. Schmidt M. L., Salwen H. R., Manohar C. F., Ikegaki N., Cohn S. L. The biological effects of antisense N-myc expression in human neuroblastoma. Cell Growth Differ. 5:1994;171-178.
13. Schneider E., Horton J. K., Yang C.-H., Nakagawa M., Cowan K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:1994;152-158.
14. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res. 54:1994;5788-5792.
15. Haber M, Norris MD, Kavallaris M, et al. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res 1989, 49, 5281-5287.
16. Ryan K. M., Birnie G. D. Myc oncogenes: the enigmatic family. Biochem J. 314:1996;713-721.
17. Zimmerman KA, Yancopoulos GD, Collum RG, et al. Differential expression of myc family genes during murine development. Nature 1986, 319, 780-783.
18. Grady E. F., Schwab M., Rosenau M. Expression of N-myc and c-src during the development of fetal human brain. Cancer Res. 47:1987;2931-2936.
19. Blackwell TK, Huang J, Ma A, et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 1993, 13, 5216-5224.
20. Zhu Q., Center M. S. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res. 54:1994;4488-4492.
21. Gaubatz S., Meichle A., Eilers M. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol Cell Biol. 14:1994;3853-3862.
22. Bello-Fernandez C., Packham G., Cleveland J. L. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc Natl Acad Sci USA. 90:1993;7804-7808.
23. Slavc I, Ellenbogen R, Jung W-H, et al. myc gene amplification and expression in primary human neuroblastoma. Cancer Res 1990, 50, 1459-1463.
24. Grady-Leopardi E. F., Schwab M., Ablin A. R., Rosenau W. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. Cancer Res. 46:1986;3196-3199.
25. Nisen PD, Wabwe PG, Rich MA, et al. N-myc oncogene RNA expression in neuroblastoma. J Natl Cancer Inst 1988, 80, 1633-1637.
26. Nakagawara A, Kadomatsu K, Sato S, et al. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Cancer Res 1990, 50, 3043-3047.
27. Nakagawara A., Arima-Nakagawara M., Scavarda N. J., et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 328:1993;847-854.
28. Joshi VV, Cantor AB, Altshuler G, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. Cancer 1992, 69, 2197-2211.
29. Evans A. E., D'Angio G., Properet K., Anderson J., Hann H. L. Prognostic factors in neuroblastoma. Cancer. 59:1987;1853-1859.